Ora Biomedical, a pharmaceutical company that is pioneering novel small molecules to maximize healthy lifespan for humans and companion pets, is excited to announce its strategic collaboration with Lifespan.io as the official charity partner for the Million-Molecule Challenge.
The Million-Molecule Challenge, hosted by Ora Biomedical, is a groundbreaking initiative aimed at accelerating research in aging and longevity by testing one million small molecule interventions directly for increased healthy lifespan using its massively high-throughput ‘WormBot-AI’ robotics and machine learning drug discovery platform.
Dr. Mitchell Lee, CEO of Ora Biomedical, expressed enthusiasm about the partnership, stating, “At Ora Biomedical, we are driven by a passion to transform healthy aging. Teaming up with Lifespan.io for the Million-Molecule Challenge aligns with both group’s missions to contribute to advancements in the field of aging and longevity. We are very excited to work with Lifespan.io to broaden the reach and impact of the Million-Molecule Challenge by accelerating our search to find the very best lifespan-extending small molecule treatments.”
Donating to support the Million-Molecule Challenge through Lifespan.io creates an unprecedented opportunity for the global community to support groundbreaking research that will directly contribute to the development of innovative interventions to address healthy aging and age-related diseases.
“We are thrilled to be both a fiscal sponsor and the official charity partner for Ora Biomedical’s Million Molecule Challenge,” said Stephanie Dainow, Executive Director of Lifespan.io. “Their commitment to advancing biomedical research aligns perfectly with our mission to accelerate progress across the longevity biotech industry. Together, we aim to catalyze support for transformative projects that have the potential to reshape the future of healthcare and improve the quality of life for millions.”
Lifespan.io encourages individuals, businesses, and organizations to join them in supporting Ora Biomedical’s efforts to complete the Million-Molecule Challenge. To make a donation or learn more about the initiative, please visit https://www.lifespan.io/the-million-molecule-challenge/.
For media inquiries, please contact:
Ora Biomedical Media Contact
Dr. Mitchell Lee
CEO
Lifespan.io Media Contact
Steve Hill
Editor-in-Chief
About Ora Biomedical
Ora Biomedical is a longevity biotechnology company that identifies and develops small molecules that target the mechanisms that drive aging. Ora Biomedical uses the “WormBot-AI”, its massively high-throughput, best-in-class robotics + AI platform, to perform high-precision phenotypic testing in live animals with lifespan and healthspan as primary endpoints. The Million-Molecule Challenge is one of Ora Biomedical’s flagship initiatives designed to accelerate research in aging and longevity by discovering breakthrough longevity therapeutics. For more information, please visit www.orabiomedical.com
About Lifespan.io
Lifespan.io is a leading nonprofit advocacy foundation and online platform committed to advancing the science of aging and promoting healthy human lifespan. By supporting groundbreaking research projects, disseminating educational resources, and raising public awareness about the importance of longevity biotechnology, Lifespan.io aims to accelerate the development of therapies that can improve the quality of life for people worldwide. With a focus on collaboration and innovation, Lifespan.io is driving the conversation on aging research and transforming the way we approach health and wellness throughout our lives. For more information, please visit www.lifespan.io.